Activity value 76greece Buyer&Supplier,Last transaction date:
2026-02-21
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for kleva pharmaceuticals s.a. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 25 transactions, with a transaction quantity of 340 and a transaction weight of 0.
YearTransactionsQuantityWeight
20255337651.140
2026253400
Bill of lading data
<
1/15
>
Trade date
2026/02/21
B/L No.
4821823
Suppliers
kleva pharmaceuticals s.a.
Buyers
invitro research solutions pvt ltd.
Hs code
30049099
Product tags
t 24,mat,vial,ophthalmic solution,pro,bimatoprost,vb
Product description
BIMATOPROST OPHTHALMIC SOLUTION 0 01 % LOT 240135 QTY 20 VIALS FOC NCV OTHER AS PER INVBIMATOPROST OPHTHALMIC SOLUTION 0 01 % LOT 240135 QTY 20 VIA
Expand
Product description
BIMATOPROST OPHTHALMIC SOLUTION 0 01 % CONTROL SAMPLE IN GLASS BOTTLE QTY 1 VIALS FOC NCV OTHER AS PER INVBIMATOPROST OPHTHALMIC SOLUTION 0 01 % CONTROL SAMPLE IN G
Expand
Hs code
30049099
Product tags
t 24,mat,vial,ophthalmic solution,pro,bimatoprost,vb
Product description
BIMATOPROST OPHTHALMIC SOLUTION 0 01 % LOT 240138 QTY 15 VIALS FOC NCV OTHER AS PER INVBIMATOPROST OPHTHALMIC SOLUTION 0 01 % LOT 240138 QTY 15 VIA
Expand
Hs code
30049099
Product tags
t 24,mat,vial,ophthalmic solution,pro,bimatoprost,vb
Product description
BIMATOPROST OPHTHALMIC SOLUTION 0 01 % LOT 240134 QTY 20 VIALS FOC NCV OTHER AS PER INVBIMATOPROST OPHTHALMIC SOLUTION 0 01 % LOT 240134 QTY 20 VIA
Expand
Hs code
30049099
Product tags
t 24,mat,vial,ophthalmic solution,pro,bimatoprost,vb
Product description
BIMATOPROST OPHTHALMIC SOLUTION 0 01 % LOT 240136 QTY 15 VIALS FOC NCV OTHER AS PER INVBIMATOPROST OPHTHALMIC SOLUTION 0 01 % LOT 240136 QTY 15 VIA
Expand
Hs code
30049099
Product tags
t 24,mat,vial,ophthalmic solution,pro,bimatoprost,vb
Product description
BIMATOPROST OPHTHALMIC SOLUTION 0 01 % LOT 240137 QTY 15 VIALS FOC NCV OTHER AS PER INVBIMATOPROST OPHTHALMIC SOLUTION 0 01 % LOT 240137 QTY 15 VIA
Expand
Hs code
30049099
Product tags
t 24,mat,vial,ophthalmic solution,pro,bimatoprost,vb
Product description
BIMATOPROST OPHTHALMIC SOLUTION 0 01 % LOT 240135 QTY 20 VIALS FOC NCV OTHER AS PER INVBIMATOPROST OPHTHALMIC SOLUTION 0 01 % LOT 240135 QTY 20 VI
Expand
Product description
BIMATOPROST OPHTHALMIC SOLUTION 0 03 % CONTROL SAMPLE IN GLASS BOTTLE QTY 1 VIALS FOC NCV OTHER AS PER INVBIMATOPROST OPHTHALMIC SOLUTION 0 03 % CONTROL SAMPLE IN G
Expand
5тов мові хелс
ukrainebuyer,they trade on 2016-07-18
40.25%
>
+View All
Products
Total 69
ProductsTransactionsPerDetail
alu 4746.53%>
tacrolimus 3938.61%>
ointment 3534.65%>
ems 2423.76%>
ophthalmic solution 2120.79%>
+View All
Hscode rank
Total 7
HSCode NameTransactionsPerDetail
HS 300490998685.15%>
HS 9802000065.94%>
HS 3004209943.96%>
HS 3004903043.96%>
HS 2933999010.99%>
Trading Area
Total 3
AreaTransactionsPerDetail
india1609.96%>
vietnam191.18%>
ukraine40.25%>
Port statistics
Total 4
Port NameTransactionsPerDetail
ua київ30.19%>
athens athinai gr20.12%>
athens athinai10.06%>
piraeus gr10.06%>
kleva pharmaceuticals s.a. is greece Buyer&Supplier,
and primarily engages in the import and export business of products such as alu,tacrolimus,ointment.
According to the 52wmb.com global trade database, as of 2026-02-21, the company has completed 1607 international trades,
with its main trading regions covering india,vietnam,ukraine etc.
The core products include HS30049099,HS98020000,HS30042099 etc,
often transported via ua київ,port athens athinai gr, port athens athinai etc,
and its main trading partners are jamp india pharmaceuticals pvt ltd.,auxilla pharmaceuticals&research llp,invitro research solutions pvt ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on kleva pharmaceuticals s.a. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.